Cargando…
Poor response to rivaroxaban in nephrotic syndrome with acute deep vein thrombosis: A case report
RATIONALE: Hypercoagulability can lead to thromboembolic events that are a life-threatening complication of nephrotic syndrome (NS). Conventional anticoagulants are first-line treatment in the presence of demonstrated thrombosis in NS. Direct-acting oral anticoagulants (DOACs) have provided useful a...
Autores principales: | Li, Yan, Chen, Yikuan, Qi, Xiaotong, Hu, Bangqin, Du, Qingqing, Qian, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709193/ https://www.ncbi.nlm.nih.gov/pubmed/31374026 http://dx.doi.org/10.1097/MD.0000000000016585 |
Ejemplares similares
-
Comparison of the efficacy and safety between rivaroxaban and dabigatran in the treatment of acute portal vein thrombosis in cirrhosis
por: Zhou, Haonan, et al.
Publicado: (2023) -
Acute renal vein thrombosis and nephrotic syndrome in the setting of retroperitoneal fibrosis
por: Wilson, Matthew Whitaker, et al.
Publicado: (2015) -
Recurrent acute portal vein thrombosis in liver cirrhosis treated by rivaroxaban
por: Yang, Hyeyoung, et al.
Publicado: (2016) -
Portal Vein Thrombosis: A Rare Complication of Nephrotic Syndrome
por: Gera, D. N., et al.
Publicado: (2018) -
Remarkable regression of massive deep vein thrombosis in response to intensive oral rivaroxaban treatment
por: Koitabashi, Norimichi, et al.
Publicado: (2015)